Related Experiment Videos
Idiopathic pulmonary fibrosis: current concepts
J H Ryu1, T V Colby, T E Hartman
1Division of Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Minnesota 55905, USA.
Mayo Clinic Proceedings
|November 18, 1998
Summary
Idiopathic pulmonary fibrosis (IPF) is a heterogeneous lung disease. Restricting the IPF diagnosis to usual interstitial pneumonia will improve patient prognosis and management.
Area of Science:
- Pulmonology
- Pathology
- Radiology
Background:
- Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease of unknown cause.
- Current treatments for IPF are unsatisfactory, with limited therapeutic options.
- Advances in imaging and histopathology have challenged the traditional concept of IPF.
Purpose of the Study:
- To re-evaluate the definition and classification of IPF.
- To differentiate between various clinicopathologic entities previously grouped under IPF.
- To improve prognostic accuracy and guide optimal patient management.
Main Methods:
- Review of high-resolution computed tomography (HRCT) findings.
- Analysis of histopathologic patterns of interstitial pneumonias.
- Correlation of clinicopathologic findings with clinical course and prognosis.
Main Results:
- IPF is likely a heterogeneous disorder, not a single entity.
- Usual interstitial pneumonia (UIP) is the most common histologic pattern in previously defined IPF cases.
- UIP is associated with a median survival of less than 3 years.
Conclusions:
- The term IPF should be restricted to patients with UIP.
- Distinguishing between different idiopathic interstitial pneumonias is crucial for accurate prognosis.
- Recognizing IPF heterogeneity will enhance patient management and therapeutic strategies.